Loading the peptide page…
Loading the peptide page…
A Russian 'bioregulator' tripeptide aimed at cartilage — with very limited evidence.
Last reviewed Oct 7, 2026 · How we rate evidence · Report an error
Cartalax is a three-amino-acid peptide (alanine-glutamic acid-aspartic acid) from the short-peptide 'bioregulator' program of Vladimir Khavinson in St Petersburg. It is promoted for cartilage, joint and connective-tissue aging. Almost all research comes from that group, mainly in cell cultures and animals, published largely in Russian journals.
Proposed to enter cells and interact with DNA and chromatin, adjusting gene activity in cartilage and connective-tissue cells. In cell studies it is reported to influence markers of cell aging and repair. This 'gene-regulating short peptide' model has not been independently confirmed.
Evidence
1/5
Mostly in-vitro and animal work from one research group. No independent controlled human trials.
Half-life
Not characterized
Known as
AED peptide, Ala-Glu-Asp, T-31
Compare Cartalax with: PinealonEpithalonor any other →
Little or noneAlmost no published research, or only lab studies.
Mostly in-vitro and animal work from one research group. No independent controlled human trials. How we rate evidence
Reported to support cartilage and connective-tissue cell function in cell cultures.
Reported to shift aging-related markers in cultured cells.
Some users report less joint stiffness; no controlled data.
“Anecdotal” means reported by users, not shown in controlled trials. Sources
Not recommendations. These are commonly cited ranges, shown so you can see what real-world use looks like.
| Plan | Dose | Frequency | Duration | Route |
|---|---|---|---|---|
| Community Bioregulators are usually run in short courses. Doses vary widely between sources; 1–2 mg is often cited. | 1 mg | Once daily | 10–20 days, repeated a few times a year | Subcutaneous |
Set up for Cartalax. Switch vial size any time. Educational math only, not dosing advice.
At a common mix of 20 mg of Cartalax in 2 mL of water (10 mg/mL), these commonly reported doses come to the following on a U-100 insulin syringe (100 units = 1 mL). They are examples of the arithmetic, not recommendations.
| Reported plan | Dose | Draw to | Volume |
|---|---|---|---|
| Community | 1 mg | 10 units | 0.1 mL |
Concentration (mg/mL) = vial mg ÷ mL of water; units = dose (mg) ÷ concentration × 100. A different vial size or amount of water changes every number above.
Amino Club sells Cartalax as a research chemical. Its listings are research-use-only and not for human use; we show them for price tracking and their published lab reports.
Research-use-only listing — not for human use.
40% off through our link (code MYPEPSINFO applies automatically), until Dec 31, 2026.
| Size | Price | Per mg | Stock | Latest COA |
|---|---|---|---|---|
| 20 mg | $41.99 | $2.10 | In stock | 99.90% pure, lot CTX0002 ILS Labs, tested Oct 22, 2026 |
List price, checked daily since Oct 7.
| Oct 7, 2026 | $69.99 | |
| Oct 8, 2026 | $69.99 | |
| Oct 9, 2026 | $69.99 | |
| Oct 10, 2026 | $69.99 | |
| Oct 11, 2026 | $69.99 | |
| Oct 12, 2026 | $69.99 | |
| Oct 13, 2026 | $69.99 | |
| Oct 14, 2026 | $69.99 | |
| Oct 15, 2026 | $69.99 | |
| Oct 16, 2026 | $69.99 | |
| Oct 17, 2026 | $69.99 | |
| Oct 18, 2026 | $69.99 | |
| Oct 19, 2026 | $69.99 | |
| Oct 20, 2026 | $69.99 | |
| Oct 21, 2026 | $69.99 | |
| Oct 22, 2026 | $69.99 | |
| Oct 23, 2026 | $69.99 | |
| Oct 24, 2026 | $69.99 | |
| Oct 25, 2026 | $69.99 | |
| Oct 26, 2026 | $69.99 | |
| Oct 27, 2026 | $69.99 | |
| Oct 28, 2026 | $69.99 | |
| Oct 29, 2026 | $69.99 | |
| Oct 30, 2026 | $69.99 | |
| Oct 31, 2026 | $69.99 | |
| Nov 1, 2026 | $69.99 |
HPLC purity from each published lab report; lowest 99.51%.
| Aug 18, 2026 | 99.51% | lot CTX0001 |
| Oct 22, 2026 | 99.90% | lot CTX0002 |
Amino Club list prices as of Nov 1, 2026; sale prices include the 40% applied through our link. Multi-buy: 2+ units 5% off, 3+ units 7.5% off, 10+ units 40% off. Prices change; confirm on the listing.
An email when it’s back in stock, its price drops, a sale starts, or its FDA or WADA status changes.
Affiliate link: we may earn a commission at no cost to you. Disclosure
All Cartalax lab reports, lot by lot →
Diluent: Bacteriostatic water (0.9% benzyl alcohol) — allows multiple draws from one vial.
Amazon affiliate links. Disclosure
Powder
Freezer / fridge
Keep sealed vial in the freezer (−20 °C) for long-term storage; fridge (2–8 °C) is fine for a few weeks. Keep dry and out of light.
After mixing
~28 days
Refrigerate at 2–8 °C. Never freeze after mixing. Keep upright, capped, and out of light.
Travel
Keep cool
Short trips at room temperature are generally fine for powder; keep mixed vials cold.
Cartalax is not an approved drug in the US. It is sold as a research chemical.
Regulations change often — verify with the FDA, EMA, MHRA, Health Canada, TGA and WADA before acting.
A term from Russian research for very short peptides said to restore normal gene activity in specific tissues. The idea is interesting but not well supported outside that research group.
Yes. Cartalax is AED; Epithalon is AEDG — the same three amino acids plus glycine.
There's no human trial showing that. Treat claims about cartilage repair as unproven.
It depends on the mix. At a common mix of 20 mg of Cartalax in 2 mL of water (10 mg/mL), 1 mg is 10 units (0.1 mL) on a U-100 insulin syringe. The formula is dose in mg ÷ concentration in mg/mL × 100. Change the vial size or water in the calculator and the units update. This is math, not a dose recommendation.
Bacteriostatic water (0.9% benzyl alcohol) — allows multiple draws from one vial. A common mix is 20 mg + 2 mL, which gives 10 mg/mL. Less water makes a stronger mix and fewer units per dose; more water makes a weaker mix and more units. Pick the amount that lands your dose on an easy-to-read line.
Refrigerate at 2–8 °C. Never freeze after mixing. Keep upright, capped, and out of light. Plan on about 28 days once it is mixed, and discard it sooner if it turns cloudy or has particles. The calculator shows how long a vial lasts at your dose and flags a vial that outlasts its shelf life.
Evidence rating (1/5): Mostly in-vitro and animal work from one research group. No independent controlled human trials.
Legal status: Cartalax is not an approved drug in the US. It is sold as a research chemical.
See something wrong or out of date? Report an error and we’ll check it against the sources. How we review pages